Model-Integrated Evidence for Generic Drug Development – Session 1B

Presenters and a panel discuss leveraging model integrated evidence for long-acting injectables (LAIs) to reduce regulatory barriers. Presentation titles include, “Model Integrated Methods for Generic LAI Product Development and Regulatory Assessment: Current Status and Future Research Directions” and “How Can Model Integrated Evidence Accelerate LAI Generic Availability?”
Learn more at: https://www.fda.gov/drugs/news-events...
_______________________________ 
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.  
 
Upcoming Training - https://www.fda.gov/cdersbia
SBIA Listserv - https://public.govdelivery.com/accoun...
SBIA 2021 Playlist -    • 2021 CDER Small Business and Industry...  
SBIA LinkedIn:   / cder-small-business-and-industry-assistance  
SBIA Training Resources - https://www.fda.gov/cdersbialearn
Twitter -   / fda_drug_info  
Email - [email protected]  
Phone - (301) 796-6707 I (866) 405-5367